Evaluating a combined treatment for trauma and sleep in childre

Not Applicable

Recruiting

Conditions: posttraumatic stress disorder
sleep disturbance
Mental Health - Other mental health disorders
Neurological - Other neurological disorders

Registration Number: ACTRN12624000056594

Lead Sponsor: Flinders University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 16

Inclusion Criteria

All participants must endorse at least one potentially traumatic event with more than 4 weeks elapsed since exposure and must meet the cut-off for clinically relevant level of symptoms (ages 5-6: equal to or greater than 16; ages 7-12: equal to or greater than 21) on the Child and Adolescent Trauma Screen (CATS). In addition, participants must endorse the two sleep items (having bad dreams related to a stressful event, trouble falling or staying asleep) as having bothered the child in the last two weeks at least half the time' or 'almost always'.

Guardian(s) must be willing to participate in the trial, and willing to travel to Flinders University’s Bedford Park campus for the initial assessment meeting, once per week for 10 weeks for treatment sessions, and again three months after the final treatment session for the follow-up assessment.

Exclusion Criteria

Exclusion criteria for the study include currently accessing psychological or pharmacological treatment for posttraumatic stress or sleep disturbance, significant suicidal intent or risk of harm, diagnosis of a neurodevelopmental disorder as these are known to impact on sleep disturbance in complex ways that are outside the scope of the present study, significant psychiatric co-morbidity that precludes engagement in active therapy, moderate to severe traumatic brain injury or cognitive impairment, and ongoing trauma exposure (e.g., family violence).

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in PTSD symptom severity[The Clinician-Administered PTSD Scale for DSM-5 - Child/Adolescent Version (CAPS-CA) At baseline, Session 4, treatment completion (after completing Session 10), and 3-month post-treatment completion follow-up];Change in sleep efficiency[Acticgraphy measured by a wristwatch worn over a week period At baseline, Session 4, treatment completion (after completing Session 10), and 3-month post-treatment completion follow-up];Change in PTSD symptom severity[The Child Behaviour Checklist (CBC-L) At baseline, Session 4, treatment completion (after completing Session 10), and 3-month post-treatment completion follow-up]

Secondary Outcome Measures